Spanish pharmaceutical company Grifols SA said March 20 that it will acquire privately held Haema AG for €220 million.
Grifols will acquire the Germany-based plasma collector from Aton GmbH, an investment firm.
Haema owns and operates Germany's largest independent network of blood donation and transfusion service centers and employs about 1,100 people, Grifols said in the filing.
The deal will include 35 donation centers in nine states plus three more under construction, a 24,000-square-meter building in Leipzig where the company's headquarters are, and a central laboratory in Berlin.
Barcelona-based Grifols operates 190 blood collection facilities in the U.S. and plans to expand its existing network. The Haema donation centers will represent Grifols' first outside the U.S.
The closing of the transaction will be funded on a debt-free basis and is subject to customary closing conditions, including authorization by the German antitrust authorities.
Osborne Clarke SLP acted as legal adviser for the deal.